Phyllis L Yan
Overview
Explore the profile of Phyllis L Yan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
95
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hsi R, Yan P, Maalouf N, Best S, Asplin J, Shahinian V, et al.
JAMA Netw Open
. 2024 Aug;
7(8):e2428953.
PMID: 39172453
No abstract available.
2.
Hsi R, Crivelli J, Yan P, Shahinian V, Hollingsworth J
Urol Pract
. 2023 Dec;
11(1):172-178.
PMID: 38117963
Introduction: Clinical guidelines recommend monitoring for metabolic derangements while on preventive pharmacologic therapy for kidney stone disease. The study objective was to compare the frequency of side effects among patients...
3.
Crivelli J, Yan P, Shahinian V, Hsi R, Hollingsworth J
Urol Pract
. 2023 Jun;
10(4):400-406.
PMID: 37341368
Introduction: The AUA Medical Management of Kidney Stones guideline outlines recommendations on follow-up testing for patients prescribed preventive pharmacological therapy. We evaluated adherence to these recommendations by provider specialty. Methods:...
4.
Hsi R, Yan P, Crivelli J, Goldfarb D, Shahinian V, Hollingsworth J
Urology
. 2022 May;
166:111-117.
PMID: 35545149
Objective: To compare the frequency of stone-related events among patients receiving thiazides, alkali citrate, and allopurinol without prior 24 h urine testing. It is unknown whether 1 preventative pharmacological therapy...
5.
Hsi R, Yan P, Crivelli J, Goldfarb D, Shahinian V, Hollingsworth J
Urology
. 2022 Feb;
164:74-79.
PMID: 35182586
Objective: To compare the frequency of stone-related events among subgroups of high-risk patients with and without 24-hour urine testing before preventive pharmacological therapy (PPT) prescription. While recent studies show, on...
6.
Hollingsworth J, Yu X, Yan P, Yoo H, Telem D, Yankah E, et al.
Circ Cardiovasc Qual Outcomes
. 2021 Apr;
14(5):e007778.
PMID: 33926210
Background: Studies have shown that Black patients die more frequently following coronary artery bypass grafting than their White counterparts for reasons not fully explained by disease severity or comorbidity. To...
7.
Hsi R, Yan P, Goldfarb D, Egbuji A, Si Y, Shahinian V, et al.
Urology
. 2020 Dec;
149:81-88.
PMID: 33352163
Objective: To assess the effectiveness of an empiric approach to metabolic stone prevention. Methods: Using medical claims from a cohort of working age adults with kidney stone diagnoses (2008-2017), we...
8.
Bakre S, Hollingsworth J, Yan P, Lawton E, Hirth R, Shahinian V
Clin J Am Soc Nephrol
. 2020 Nov;
15(12):1777-1784.
PMID: 33234541
Background And Objectives: Despite representing 1% of the population, beneficiaries on long-term dialysis account for over 7% of Medicare's fee-for-service spending. Because of their focus on care coordination, Accountable Care...
9.
Lin S, Yan P, Moloci N, Lawton E, Ryan A, Adler-Milstein J, et al.
Health Aff (Millwood)
. 2020 Feb;
39(2):310-318.
PMID: 32011939
Despite expectations that Medicare accountable care organizations (ACOs) would curb health care spending, their effect has been modest. One possible explanation is that ACOs' inability to prohibit out-of-network care limits...
10.
Tam C, Dauw C, Ghani K, Gunaseelan V, Kim T, Leavitt D, et al.
Urology
. 2019 Sep;
134:103-108.
PMID: 31536742
Objective: To measure the incidence of persistent opioid use following ureteroscopy (URS). Over 100 Americans die every day from opioid overdose. Recent studies suggest that many opioid addictions surface after...